Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis

Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis

Background: Non-small cell lung cancer (NSCLC) is the most common form of lung cancer. Some epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutations make tumours responsive to treatment with EGFR-TK inhibitors (EGFR-TKIs) but less responsive to treatment with standard chemotherapy. Patie...

Full description

Bibliographic Details
Main Authors: Marie Westwood, Manuela Joore, Penny Whiting, Thea van Asselt, Bram Ramaekers, Nigel Armstrong, Kate Misso, Johan Severens, Jos Kleijnen
Format: Article
Language:English
Published: NIHR Journals Library 2014-05-01
Series:Health Technology Assessment
Subjects:
epidermal growth factor receptor tyrosine kinase
mutation
testing
non-small-cell lung cancer
metastasis
systematic review
cost-effectiveness
Online Access:https://doi.org/10.3310/hta18320

Internet

https://doi.org/10.3310/hta18320

Similar Items